Diagnostic accuracy of whole-body MRI versus standard imaging pathways for metastatic disease in newly diagnosed non-small-cell lung cancer: the prospective Streamline L trial

Lancet Respiratory Medicine,The - Tập 7 - Trang 523-532 - 2019
Stuart A Taylor1, Sue Mallett2, Simon Ball3, Sandy Beare4, Gauraang Bhatnagar5, Angshu Bhowmik6, Peter Boavida7, John Bridgewater8, Caroline S Clarke9, Marian Duggan4, Steve Ellis10, Robert Glynne-Jones11, Vicky Goh12, Ashley M Groves13, Ayshea Hameeduddin10, Sam M Janes14,15, Edward W Johnston1, Dow-Mu Koh16, Sara Lock17, Anne Miles18
1Centre for Medical Imaging, University College London, London, UK
2Institute of Applied Health Research, NIHR Birmingham Biomedical Research Centre, College of Medical and Dental Sciences, University of Birmingham, Edgbaston, Birmingham, UK
3Barking, Havering, and Redbridge NHS Trust, Romford, UK
4Cancer Research UK & UCL Cancer Trials Centre, University College London, London, UK
5Frimley Park Hospital, Frimley, UK
6Department of Respiratory Medicine, Homerton University Hospital, London, UK
7Department of Radiology, Homerton University Hospital, London, UK
8UCL Cancer Institute, London, UK
9Research Department of Primary Care and Population Health, University College London, London, UK
10Department of Radiology, Barts Health NHS Trust, London, UK
11Mount Vernon Centre for Cancer Treatment, Mount Vernon Hospital, Northwood, UK
12Department of Cancer Imaging, School of Biomedical Engineering and Imaging Sciences, King's College London, King's Health Partners, London, UK
13Institute of Nuclear Medicine, University College London, London, UK
14Lungs for Living Research Centre, UCL Respiratory, University College London, London, UK
15Department of Thoracic Medicine, University College London Hospitals, UK
16Department of Radiology, Royal Marsden Hospital, Sutton, Surrey UK
17Department of Respiratory Medicine, Whittington Hospital, London, UK
18Department of Psychological Sciences, Birkbeck, University of London, London, UK

Tài liệu tham khảo

Gilligan, 2007, Preoperative chemotherapy in patients with resectable non-small cell lung cancer: results of the MRC LU22/NVALT 2/EORTC 08012 multicentre randomised trial and update of systematic review, Lancet, 369, 1929, 10.1016/S0140-6736(07)60714-4

Taylor, 2017, Streamlining staging of lung and colorectal cancer with whole body MRI; study protocols for two multicentre, non-randomised, single-arm, prospective diagnostic accuracy studies (Streamline C and Streamline L), BMC Cancer, 17, 299, 10.1186/s12885-017-3281-x

Shah, 2012, Radiation-induced cancer: a modern view, Br J Radiol, 85, e1166, 10.1259/bjr/25026140

Brocken, 2012, The faster the better? A systematic review on distress in the diagnostic phase of suspected cancer, and the influence of rapid diagnostic pathways, Psychooncology, 21, 1, 10.1002/pon.1929

Xu, 2013, Comparison of FDG whole-body PET/CT and gadolinium-enhanced whole-body MRI for distant malignancies in patients with malignant tumors: a meta-analysis, Ann Oncol, 24, 96, 10.1093/annonc/mds234

Duo, 2013, Comparison of FDG PET/CT and gadolinium-enhanced MRI for the detection of bone metastases in patients with cancer: a meta-analysis, Clin Nucl Med, 38, 343, 10.1097/RLU.0b013e3182817af3

Li, 2014, Diagnostic value of whole-body diffusion-weighted magnetic resonance imaging for detection of primary and metastatic malignancies: a meta-analysis, Eur J Radiol, 83, 338, 10.1016/j.ejrad.2013.11.017

Liu, 2011, Fluorine-18 deoxyglucose positron emission tomography, magnetic resonance imaging and bone scintigraphy for the diagnosis of bone metastases in patients with lung cancer: which one is the best? A meta-analysis, Clin Oncol (R Coll Radiol), 23, 350, 10.1016/j.clon.2010.10.002

Wu, 2011, Diagnostic value of whole-body magnetic resonance imaging for bone metastases: a systematic review and meta-analysis, J Magn Reson Imaging, 34, 128, 10.1002/jmri.22608

Yang, 2011, Diagnosis of bone metastases: a meta-analysis comparing 18FDG PET, CT, MRI and bone scintigraphy, Eur Radiol, 21, 2604, 10.1007/s00330-011-2221-4

Qu, 2012, A meta-analysis of 18FDG-PET-CT, 18FDG-PET, MRI and bone scintigraphy for diagnosis of bone metastases in patients with lung cancer, Eur J Radiol, 81, 1007, 10.1016/j.ejrad.2011.01.126

Wu, 2013, Comparison of whole-body MRI and skeletal scintigraphy for detection of bone metastatic tumors: a meta-analysis, Surg Oncol, 22, 261, 10.1016/j.suronc.2013.10.004

Smets, 2018, Whole-body magnetic resonance imaging for detection of skeletal metastases in children and young people with primary solid tumors—systematic review, Pediatr Radiol, 48, 241, 10.1007/s00247-017-4013-8

Peerlings, 2016, The diagnostic value of MR imaging in determining the lymph node status of patients with non-small cell lung cancer: a meta-analysis, Radiology, 281, 86, 10.1148/radiol.2016151631

Shen, 2016, Performance of DWI in the nodal characterization and assessment of lung cancer: a meta-analysis, AJR Am J Roentgenol, 206, 283, 10.2214/AJR.15.15032

Wu, 2012, Preoperative mediastinal and hilar nodal staging with diffusion-weighted magnetic resonance imaging and fluorodeoxyglucose positron emission tomography/computed tomography in patients with non-small-cell lung cancer: which is better?, J Surg Res, 178, 304, 10.1016/j.jss.2012.03.074

Ferrante di Ruffano, 2012, Assessing the value of diagnostic tests: a framework for designing and evaluating trials, BMJ, 344, e686, 10.1136/bmj.e686

Taylor, 2019, Diagnostic accuracy of whole-body MRI versus standard imaging pathways for metastatic disease in newly diagnosed colorectal cancer: the prospective Streamline C trial, Lancet Gastroenterol Hepatol, 10.1016/S2468-1253(19)30056-1

2010

Ohno, 2008, Non-small cell lung cancer: whole-body MR examination for M-stage assessment--utility for whole-body diffusion-weighted imaging compared with integrated FDG PET/CT, Radiology, 248, 643, 10.1148/radiol.2482072039

Rutjes, 2007, Evaluation of diagnostic tests when there is no gold standard. A review of methods, Health Technol Assess, 11, 50, 10.3310/hta11500

Evans, 2018, Perceived patient burden and acceptability of whole body MRI for staging lung and colorectal cancer; comparison with standard staging investigations, Br J Radiol, 91, 20170731, 10.1259/bjr.20170731

Evans, 2017, Patient experience and perceived acceptability of whole-body magnetic resonance imaging for staging colorectal and lung cancer compared with current staging scans: a qualitative study, BMJ Open, 7, e016391, 10.1136/bmjopen-2017-016391

Miles, 2019, Patient preferences for whole-body MRI or conventional staging pathways in lung and colorectal cancer: a discrete choice experiment, Eur Radiol, 10.1007/s00330-019-06153-4

Alonzo, 2002, Sample size calculations for comparative studies of medical tests for detecting presence of disease, Stat Med, 21, 835, 10.1002/sim.1058

Newcombe, 1998, Improved confidence intervals for the difference between binomial proportions based on paired data, Stat Med, 17, 2635, 10.1002/(SICI)1097-0258(19981130)17:22<2635::AID-SIM954>3.0.CO;2-C

Navani, 2019, The accuracy of clinical staging of stage I-IIIa non-small cell lung cancer: an analysis based on individual participant data, Chest, 155, 502, 10.1016/j.chest.2018.10.020

Fischer, 2009, Preoperative staging of lung cancer with combined PET-CT, N Engl J Med, 361, 32, 10.1056/NEJMoa0900043

Padhani, 2017, Metastasis reporting and data system for prostate cancer: practical guidelines for acquisition, interpretation, and reporting of whole-body magnetic resonance imaging-based evaluations of multiorgan involvement in advanced prostate cancer, Eur Urol, 71, 81, 10.1016/j.eururo.2016.05.033

Navani, 2015, Lung cancer diagnosis and staging with endobronchial ultrasound-guided transbronchial needle aspiration compared with conventional approaches: an open-label, pragmatic, randomised controlled trial, Lancet Respir Med, 3, 282, 10.1016/S2213-2600(15)00029-6

Silvestri, 2013, Methods for staging non-small cell lung cancer: Diagnosis and management of lung cancer, 3rd ed: American College of Chest Physicians evidence-based clinical practice guidelines, Chest, 143, e211S, 10.1378/chest.12-2355

Maconachie, 2019, Lung cancer: diagnosis and management: summary of updated NICE guidance, BMJ, 364, l1049, 10.1136/bmj.l1049

Kubo, 2019, Vendor free basics of radiation dose reduction techniques for CT, Eur J Radiol, 110, 14, 10.1016/j.ejrad.2018.11.002

Olchowy, 2017, The presence of the gadolinium-based contrast agent depositions in the brain and symptoms of gadolinium neurotoxicity—a systematic review, PLoS One, 12, e0171704, 10.1371/journal.pone.0171704

Thông tin
Thông tin xuất bản

Lancet Respiratory Medicine,The

Tập 7

523-532

Thông tin tác giả